TrianglePhotodynamic Therapy (NCT06307548)
Photodynamic Therapy trial for Locally Advanced or Recurrent Colorectal Cancer (NCT06307548). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with locally advanced or recurrent colorectal cancer who are having surgery.
The idea: patients take aminolevulinic acid, a light activated drug, by mouth before surgery. After the tumor is removed, fluorescence imaging checks the area, and then photodynamic therapy, using light, treats it during the same operation.
This phase 1 and 2 study plans 21 patients and aims to improve local tumor control. At Roswell Park Cancer Institute in Buffalo, Anthony Dakwar leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.